Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.
Identifieur interne : 001C07 ( PubMed/Checkpoint ); précédent : 001C06; suivant : 001C08Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.
Auteurs : Michelle Chonwerawong ; Patrick Avé [France] ; Michel Huerre [France] ; Richard L. FerreroSource :
- Gut pathogens [ 1757-4749 ] ; 2016.
Abstract
Mouse infection studies have shown that interferon-γ (IFN-γ), a T helper 1 (Th1) cytokine, is required for the development of severe pathology induced by chronic Helicobacter infection. This finding is largely based on studies performed using mice that have polarised Th1 responses i.e. C57BL/6 animals. The current work aims to investigate the role of IFN-γ in Helicobacter-induced inflammation in BALB/c mice which have Th2-polarised immune responses.
DOI: 10.1186/s13099-016-0142-0
PubMed: 27895717
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:27895717Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.</title><author><name sortKey="Chonwerawong, Michelle" sort="Chonwerawong, Michelle" uniqKey="Chonwerawong M" first="Michelle" last="Chonwerawong">Michelle Chonwerawong</name><affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</nlm:affiliation><wicri:noCountry code="subField">VIC 3123 Australia</wicri:noCountry></affiliation></author><author><name sortKey="Ave, Patrick" sort="Ave, Patrick" uniqKey="Ave P" first="Patrick" last="Avé">Patrick Avé</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Huerre, Michel" sort="Huerre, Michel" uniqKey="Huerre M" first="Michel" last="Huerre">Michel Huerre</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name><affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</nlm:affiliation><wicri:noCountry code="subField">VIC Australia</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27895717</idno><idno type="pmid">27895717</idno><idno type="doi">10.1186/s13099-016-0142-0</idno><idno type="wicri:Area/PubMed/Corpus">001639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001639</idno><idno type="wicri:Area/PubMed/Curation">001617</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001617</idno><idno type="wicri:Area/PubMed/Checkpoint">001617</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001617</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.</title><author><name sortKey="Chonwerawong, Michelle" sort="Chonwerawong, Michelle" uniqKey="Chonwerawong M" first="Michelle" last="Chonwerawong">Michelle Chonwerawong</name><affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</nlm:affiliation><wicri:noCountry code="subField">VIC 3123 Australia</wicri:noCountry></affiliation></author><author><name sortKey="Ave, Patrick" sort="Ave, Patrick" uniqKey="Ave P" first="Patrick" last="Avé">Patrick Avé</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Huerre, Michel" sort="Huerre, Michel" uniqKey="Huerre M" first="Michel" last="Huerre">Michel Huerre</name><affiliation wicri:level="3"><nlm:affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name><affiliation><nlm:affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</nlm:affiliation><wicri:noCountry code="subField">VIC Australia</wicri:noCountry></affiliation></author></analytic><series><title level="j">Gut pathogens</title><idno type="ISSN">1757-4749</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mouse infection studies have shown that interferon-γ (IFN-γ), a T helper 1 (Th1) cytokine, is required for the development of severe pathology induced by chronic Helicobacter infection. This finding is largely based on studies performed using mice that have polarised Th1 responses i.e. C57BL/6 animals. The current work aims to investigate the role of IFN-γ in Helicobacter-induced inflammation in BALB/c mice which have Th2-polarised immune responses.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27895717</PMID><DateCreated><Year>2016</Year><Month>11</Month><Day>29</Day></DateCreated><DateRevised><Year>2017</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1757-4749</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Gut pathogens</Title><ISOAbbreviation>Gut Pathog</ISOAbbreviation></Journal><ArticleTitle>Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.</ArticleTitle><Pagination><MedlinePgn>61</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mouse infection studies have shown that interferon-γ (IFN-γ), a T helper 1 (Th1) cytokine, is required for the development of severe pathology induced by chronic Helicobacter infection. This finding is largely based on studies performed using mice that have polarised Th1 responses i.e. C57BL/6 animals. The current work aims to investigate the role of IFN-γ in Helicobacter-induced inflammation in BALB/c mice which have Th2-polarised immune responses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At 7 months post-infection with Helicobacter felis, IFN-γ deficiency in BALB/c mice had no significant effect on H. felis colonisation levels in the gastric mucosa, nor on humoral responses, or gastritis severity. Ifng(-/-) animals with chronic H. felis infection did, however, develop significantly fewer lymphoid follicle lesions, as well as increased IL-4 splenocyte responses, when compared with infected Ifng(+/+) mice (P = 0.015 and P = 0.0004, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The work shows that in mice on a BALB/c background, IFN-γ is not required for bacterial clearance, antibody responses, nor gastric inflammation. Conversely, IFN-γ appears to play a role in the development of gastric lymphoid follicles, which are precursor lesions to mucosa-associated lymphoid tissue (MALT) lymphoma. This study highlights the importance of mouse host background on the susceptibility to Helicobacter-induced pathologies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chonwerawong</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avé</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Unité de Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huerre</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unité de Recherche et d'Expertise Histotechnologie et Pathologie, Institut Pasteur, 25-28 Rue du Dr Roux, 75724 Paris, France ; Département de Pathologie, Institut Curie, 26 Rue d'Ulm, 75248 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrero</LastName><ForeName>Richard L</ForeName><Initials>RL</Initials><Identifier Source="ORCID">0000-0001-6817-6211</Identifier><AffiliationInfo><Affiliation>Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Monash University, 27-31 Wright Street, Clayton, VIC 3123 Australia ; Department of Microbiology, Monash University, Clayton, VIC Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gut Pathog</MedlineTA><NlmUniqueID>101474263</NlmUniqueID><ISSNLinking>1757-4749</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>APMIS. 2015 Jul;123(7):571-9</RefSource><PMID Version="1">26010562</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1995 Jul;147(1):217-22</RefSource><PMID Version="1">7604881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1988 Feb 15;140(4):1022-7</RefSource><PMID Version="1">3125247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2001 Jun 15;166(12):7456-61</RefSource><PMID Version="1">11390498</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1987 May 22;236(4804):944-7</RefSource><PMID Version="1">3107127</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2010 Jun;24(6):1186-96</RefSource><PMID Version="1">20428202</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2007 Aug;133(2):659-72</RefSource><PMID Version="1">17681184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biomed Biotechnol. 2010;2010:104918</RefSource><PMID Version="1">20617132</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1999 Aug 1;163(3):1490-7</RefSource><PMID Version="1">10415051</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2008 Feb;76(2):551-61</RefSource><PMID Version="1">18070899</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1998 Oct;115(4):891-7</RefSource><PMID Version="1">9753492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 1999 Sep;45(3):335-40</RefSource><PMID Version="1">10446099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 2005 Jun;128(7):1937-52</RefSource><PMID Version="1">15940628</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2004 Nov;5(11):1166-74</RefSource><PMID Version="1">15489856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1997 Apr;112(4):1386-97</RefSource><PMID Version="1">9098027</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Prev. 2014 Sep;19(3):224-30</RefSource><PMID Version="1">25337592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1996 Jun 15;156(12):4729-38</RefSource><PMID Version="1">8648119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 2004 Aug;53(8):1082-9</RefSource><PMID Version="1">15247172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 2005 Sep;167(3):797-812</RefSource><PMID Version="1">16127158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2007 Apr;75(4):1738-44</RefSource><PMID Version="1">17220306</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1999 Dec;155(6):2019-27</RefSource><PMID Version="1">10595932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 1996 Nov;39(5):639-48</RefSource><PMID Version="1">9026476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vet Pathol. 2012 Jan;49(1):32-43</RefSource><PMID Version="1">22135019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2004 Aug;203(4):896-903</RefSource><PMID Version="1">15258991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2003 Jun;71(6):3628-33</RefSource><PMID Version="1">12761151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Scand J Gastroenterol. 2001 Nov;36(11):1198-203</RefSource><PMID Version="1">11686221</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2009 Jun 1;182(11):7085-101</RefSource><PMID Version="1">19454706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 2000 Jul;191(3):333-40</RefSource><PMID Version="1">10878557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1999 Jun;67(6):3040-6</RefSource><PMID Version="1">10338517</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 May 1;184(9):5121-9</RefSource><PMID Version="1">20351183</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Microbes Infect. 2000 May;2(6):593-7</RefSource><PMID Version="1">10884609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Gastroenterol. 2007 Jun 7;13(21):2923-31</RefSource><PMID Version="1">17589941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mucosal Immunol. 2015 Mar;8(2):279-95</RefSource><PMID Version="1">25073677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2005 Dec;142(3):498-504</RefSource><PMID Version="1">16297162</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1997 Jul;113(1):185-94</RefSource><PMID Version="1">9207277</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2013 Mar;81(3):740-52</RefSource><PMID Version="1">23264048</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 1993 Mar 19;259(5102):1742-5</RefSource><PMID Version="1">8456301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int Immunol. 1993 Aug;5(8):885-91</RefSource><PMID Version="1">8398983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Immunol Today. 1997 Feb;18(2):61-4</RefSource><PMID Version="1">9057354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Pathol. 1997 Nov;50(11):957-9</RefSource><PMID Version="1">9462249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Jun 1;186(11):6165-72</RefSource><PMID Version="1">21518972</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1997 May;150(5):1583-93</RefSource><PMID Version="1">9137085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pathol. 1996 Feb;178(2):122-7</RefSource><PMID Version="1">8683376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1997 Dec;113(6):1848-57</RefSource><PMID Version="1">9394724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1998 May;152(5):1377-86</RefSource><PMID Version="1">9588906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1999 Nov;117(5):1105-12</RefSource><PMID Version="1">10535873</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2000 Jul 15;165(2):1022-9</RefSource><PMID Version="1">10878379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gut. 1995 Mar;36(3):341-5</RefSource><PMID Version="1">7698689</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Gastroenterology. 1998 Mar;114(3):482-92</RefSource><PMID Version="1">9496938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>APMIS. 2003 Apr;111(4):514-22</RefSource><PMID Version="1">12780527</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2004 Aug;72(8):4668-79</RefSource><PMID Version="1">15271928</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2001 Mar;69(3):1714-21</RefSource><PMID Version="1">11179348</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 1999 Jan;67(1):279-85</RefSource><PMID Version="1">9864227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Immun. 2001 Nov;69(11):6749-54</RefSource><PMID Version="1">11598047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Pathol. 1998 Jun;152(6):1625-32</RefSource><PMID Version="1">9626066</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BALB/c</Keyword><Keyword MajorTopicYN="N">Gastric inflammation</Keyword><Keyword MajorTopicYN="N">Helicobacter</Keyword><Keyword MajorTopicYN="N">Interferon-gamma</Keyword><Keyword MajorTopicYN="N">Lymphoid follicle</Keyword><Keyword MajorTopicYN="N">MALT lymphoma</Keyword><Keyword MajorTopicYN="N">Mucosa-associated lymphoid tissue</Keyword><Keyword MajorTopicYN="N">T helper response</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27895717</ArticleId><ArticleId IdType="doi">10.1186/s13099-016-0142-0</ArticleId><ArticleId IdType="pii">142</ArticleId><ArticleId IdType="pmc">PMC5117576</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Chonwerawong, Michelle" sort="Chonwerawong, Michelle" uniqKey="Chonwerawong M" first="Michelle" last="Chonwerawong">Michelle Chonwerawong</name><name sortKey="Ferrero, Richard L" sort="Ferrero, Richard L" uniqKey="Ferrero R" first="Richard L" last="Ferrero">Richard L. Ferrero</name></noCountry><country name="France"><region name="Île-de-France"><name sortKey="Ave, Patrick" sort="Ave, Patrick" uniqKey="Ave P" first="Patrick" last="Avé">Patrick Avé</name></region><name sortKey="Huerre, Michel" sort="Huerre, Michel" uniqKey="Huerre M" first="Michel" last="Huerre">Michel Huerre</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C07 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C07 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:27895717
|texte= Interferon-γ promotes gastric lymphoid follicle formation but not gastritis in Helicobacter-infected BALB/c mice.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:27895717" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |